# K223725: Restrata® MiniMatrix

- Pathway: 510(k) (Traditional)
- Applicant: Acera Surgical, Inc.
- Decided: May 18, 2023 after 156 days
- Product code: QSZ (Absorbable Synthetic Wound Dressing)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 11 generations back to K842066 (1985). 83 ancestors in all.
No later device cites it as a predicate yet.
0 of 84 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K170300: Restrata Wound Matrix, Acera Surgical, Inc. (2017) Summary page 5.
- K193583: Restrata®, Acera Surgical, Inc. (2020) Summary page 5.

## Indications for use
Restrata® MiniMatrix is intended for use in the management of wounds, including: Partial and full thickness wounds, pressure sores / ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled / undermined wounds, surgical wounds (e.g., donor site / grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, dehisced wounds), trauma wounds (e.g., abrasions, lacerations, partial thickness burns, skin tears), and draining wounds.

Source page: https://510kreport.com/device/K223725
Methodology: https://510kreport.com/methodology